Cargando…
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
SIMPLE SUMMARY: New therapeutical strategies are needed to improve survival in high-grade serous ovarian cancer (HGSOC) patients. AKT inhibitors are promising agents able to act in synergy with PARP inhibitors and platinum-based therapies, but the subset of patients who could benefit from this appro...
Autores principales: | Azzalini, Eros, Tierno, Domenico, Bartoletti, Michele, Barbazza, Renzo, Giorda, Giorgio, Puglisi, Fabio, Cecere, Sabrina Chiara, Losito, Nunzia Simona, Russo, Daniela, Stanta, Giorgio, Canzonieri, Vincenzo, Bonin, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773580/ https://www.ncbi.nlm.nih.gov/pubmed/35053468 http://dx.doi.org/10.3390/cancers14020304 |
Ejemplares similares
-
Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
por: Azzalini, Eros, et al.
Publicado: (2023) -
A Novel HPLC-Based Method to Investigate on RNA after Fixation
por: Fattorini, Paolo, et al.
Publicado: (2020) -
Reliability of miRNA Analysis from Fixed and Paraffin-Embedded Tissues
por: Azzalini, Eros, et al.
Publicado: (2019) -
Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
por: Donada, Marisa, et al.
Publicado: (2013) -
Is Human Papillomavirus Associated with Prostate Cancer Survival?
por: Pascale, Mariarosa, et al.
Publicado: (2013)